Online Exclusives

2026 Medical Device Industry M&A Roundup (Updated 1/9)

MPO's catalogue of the medtech market's M&A transactions, updated throughout the year.

Author Image

By: Sam Brusco

Associate Editor

Merger and acquisition (M&A) transactions remain prevalent in the medical device manufacturing industry in many forms—large organizations purchasing smaller, innovative companies and/or businesses, mergers of equals, private equity deals, and medical product outsourcing providers grabbing specialty businesses to round out their offerings.

To help our readers stay up to date about the medical device market’s evolution, MPO will catalog these M&A transactions throughout the year. We hope this will be a helpful resource!

Haemonetics—Vivasure

Vivasure’s PerQseal Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26F) arteriotomies and venotomies from inside the vessel.
Date of Announcement: January 9, 2026
Value: Up to €185 million
More info

NAMSA—Labcorp

NAMSA will assume the U.S. portfolio of services of Labcorp’s Early Development medical device business, including biocompatibility testing, microbiological testing, analytical testing, and preclinical research.
Date of Announcement: January 8, 2026
Value: Not disclosed
More info

Arterex—Synecco

Synecco is based in Ireland and boasts expertise in the structural heart space, with the addition of injection molding and assembly capabilities.
Date of Announcement: January 6, 2026
Value: Not disclosed
More info

Alcon—STAAR Surgical (Terminated)

STAAR did not receive the necessary stockholder votes to approve the merger agreement with Alcon at its Special Meeting of Stockholders, resulting in termination.
Date of Announcement: January 6, 2026
More info

Resonetics—Med-Ally

This deal includes manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators as well as leads manufacturing and assembly.
Date of Announcement: January 6, 2026
Value: Not disclosed
More info

W.L. Gore & Associates (Gore)—Conformal Medical

Conformal Medical develops the investigational CLAAS AcuFORM system, a next-gen left atrial appendage occlusion (LAAO) device.
Date of Announcement: January 5, 2026
Value: Not disclosed
More info

Year-by-Year

2025 Medical Device Companies M&A Roundup
2024 Medical Device Manufacturing M&A Roundup

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters